National HealthCare Isn’t Done Yet: A Momentum Name With Value Math Still on Its Side
National HealthCare (NHC) has surged to new 52-week highs, but the stock still looks reasonably valued against its cash generation and improving fundamentals. With bullish technicals, low leverage, and a business tied to durable senior-care demand, this sets up as a mid-term trade where you’re paying for quality, not hype.